Wedbush Initiates Coverage on Sequenom (SQNM) with an Underperform; RNA Based Test as Good as Dead; Zero Data on DNA-based
Tweet Send to a Friend
Wedbush initiates coverage on Sequenom, Inc. (Nasdaq: SQNM) with an Underperform rating. PT $0.50.
Wedbush analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
